Dr. Alex ZhavoronkovWith a multidisciplinary background in biomedicine and computer science, he pioneered the application of generative artificial intelligence to drug discovery in 2014 and founded Insilico Medicine. In 2019, he was named one of the world's top 100 AI leaders in drug discovery and advanced healthcare, and in 2022, he was selected by Clarivate as a "Highly Cited Researcher" globally.